RECURSION PHARMACEUTICALS-A (RXRX) Stock Cash Flow
NASDAQ:RXRX - Nasdaq - US75629V1044 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -574.77M | -463.66M | -328.07M | -239.48M | -186.48M | |||
| Depreciation Amortization | 48.45M | 36.49M | 24.40M | 11.76M | 8.41M | |||
| Change In Working Capital | -7.40M | -38.00M | -50.26M | 104.92M | -310.00K | |||
| Interest Paid | N/A | N/A | 96.00K | 60.00K | 680.00K | |||
| Other non cash items | 144.90M | 105.99M | 66.14M | 39.28M | 19.77M | |||
| OPERATING CASH FLOW | -388.83M | -359.17M | -287.78M | -83.52M | -158.61M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -8.87M | -13.70M | -11.96M | -37.06M | -39.80M | |||
| Other Investing Activity | 268.32M | 273.75M | 1.73M | 230.31M | -231.95M | |||
| INVESTING CASH FLOW | 259.44M | 260.06M | -10.23M | 193.25M | -271.74M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -6.46M | -4.44M | -766.00K | -90.00K | -12.80M | |||
| Stock Issued/Repurchased | 337.21M | 308.56M | 140.90M | 154.44M | 471.34M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | 0.00 | |||
| FINANCING CASH FLOW | 330.75M | 304.12M | 140.13M | 154.35M | 458.54M | |||
| Exchange Rate Effect | 1.65M | -3.41M | 188.00K | -310.00K | N/A | |||
| CHANGE IN CASH | 203.01M | 201.60M | -157.69M | 263.77M | 28.19M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -388.83M | -359.17M | -287.78M | -83.52M | -158.61M | |||
| Capital Expenditure | -8.87M | -13.70M | -11.96M | -37.06M | -39.80M | |||
| FREE CASH FLOW | -397.70M | -372.87M | -299.74M | -120.58M | -198.41M | |||
All data in USD